Homology modeling and molecular
docking studies of DNA replication licensing factor minichromosome
maintenance protein 5 (MCM5)
Manish Devgan*
Faculty of
Pharmacy, R.P. Educational Trust Group of Institutions, Bastara,
Karnal-132001, Haryana, India.
*Corresponding Author E-mail: manishdevgan12@gmail.com
ABSTRACT:
Minichromosome
maintenance proteins (MCM2-7) form the important part of the DNA replication initiation
system. The MCM proteins contribute to restricting the initiation of DNA
replication to once per cycle. A heteromeric complex
is formed by binding of these six proteins with each other. The aim of this
work was to prepare the homologous model of MCM5 protein and perform the
docking studies. In this work, a theoretical model of MCM5 protein was
generated using the concepts of homology modeling and loop modeling. The
resulting model was validated by Procheck with Ramachandran plot analysis. The ligands generated with the
help of Drug bank and ZINC data base were docked against MCM5 protein using DockThor portal. The study revealed that the compound acetonyl-cycloheptyl-cyclohexyl-BLAHtrione (ZINC15861168)
has the maximum probability to bind with MCM5. Thus, the usage of this compound
can lead to inhibition of the protein MCM5 which will act as a blockade in the
formation of heteromeric complex of MCM2-7 proteins
thereby assisting in the treatment of multiple myeloma and other cancer cells.
KEY
WORDS: Minichromosome maintenance proteins, molecular
modeling, homology modeling, loop modeling, molecular docking.
INTRODUCTION:
Minichromosome maintenance proteins (MCM2-7) belong to a
family of evolutionarily highly sustained protein. These six proteins form the
important part of the DNA replication initiation system1,2.
The MCM proteins contribute to restricting the initiation of DNA replication to
once per cycle3,4. A heteromeric
complex is formed by binding of these six proteins with each other5.
One study showed that in addition to the role in DNA replication, the MCM
proteins are also crucial for transcription activation6.
In humans,
the MCM gene encodes the protein called as DNA replication factor MCM5. This
protein is structurally homologous to CDC46 protein from Saccharomyces cerevisiae7. Many studies have demonstrated that MCM
proteins may be better indicators of a wide variety of proliferative or cancer
cells in malignant tissues8-14. In one study it was seen that Aplidin displayed anti-multiple myeloma activity in a mouse
xenograft model, which may be due to restraining of a
collection of proliferative/ antiapoptic genes (e.g.,
MCM2, MCM4, MCM5) and up regulation of several possible regulators of apoptosis15.
Another study demonstrated that Prohibitin, a tumour suppression
protein, interacts with MCM proteins and can act as an effective inhibitor of
DNA replication16.
The most common problem in biology is the
functional characterization of a protein sequence. There are some proteins
which are too big for NMR analysis and also their structure cannot be predicted
by X-ray diffraction. This work is normally made easy by precise three
dimensional (3-D) structure of the studied protein. When experimental
techniques fail then protein modeling is the only way to extract the structural
information. Homology modeling estimates the 3-D structure of a given protein
sequence (target) based principally on its alignment to one or more proteins of
known structures (templates). The estimation process consists of fold
assignments, model building and model evaluation17,18.
One study suggested that the combination of structure-based docking and
advanced protein structure modeling should be an important approach to the
large-scale drug screening and discovery studies19. The homology modeling
has been widely used to predict the protein structure20,21.
In this study, we designed the structure of MCM5 protein, by using homology
modeling. Finally the docking of the ligands was done to predict the binding
orientation of small drug molecules with their protein target (MCM5) in order
to predict the affinity and activity of the small molecules in inhibiting MCM5
so that the MCM heteromeric complex is blocked, which
in turn will lead to inhibition of DNA replication.
Materials
And Methods:
The hardware used for calculating molecular
modeling includes a personal computer with Intel (R) Core (TM) i3 CPU
processor, Windows 7 Home Premium 32-bit operating system having RAM of 2.00
GB.
Sequence
Alignment
Fast Alignment (FASTA)
The FASTA format is a text based format for
representing either nucleotide sequences or peptide sequences, in which
nucleotides or amino acids are represented using single letter codes22.
The FASTA sequence of MCM5 was acquired from the website of National Centre for
Biotechnology Information23.
Basic Local Alignment Search Tool (BLAST)
The BLAST is an algorithm for comparing
primary biological sequence information, such as the amino acid sequence of
different proteins or the nucleotides of DNA sequences24. Using the
FASTA sequence, the standard protein BLAST was performed on the NCBI. The
protein data bank proteins data base was chosen and the BLAST-P was performed.
Three Dimensional Position-Specific Scoring
Matrix (3D-PSSM)
The 3D-PSSM is a fast web based method for
protein fold recognition using 1D and 3D sequence profiles coupled with
secondary structure and salvation potential information25. The FASTA
sequence was submitted to 3D-PSSM for fold recognition.
Protein Homology/Analogy Recognition Engine
(Phyre)
Phyre is a web based service for protein
structure prediction. Phyre is among the most popular
methods for protein structure prediction26. The FASTA sequence was
submitted to Phyre for amino acid sequence prediction27.
Templates
Preparation
The data obtained from combined 3D-PSSM and
Phyre was subjected to RCSB protein data bank28.
The templates were selected on the basis of their resolution (Å) and R-value.
All the above templates were submitted by X-ray crystallography method in PDB29.
Molecular
Modeling
Homology modeling of MCM5 was done by using
EasyModeller30. Easy Modeller is a
graphical user interface to Modeller program. It is a
standalone tool in windows platform with Modeller and
Python preinstalled31. The Swiss-Pdb
viewer was installed from the respective site which is an application that
provides a user friendly interface allowing analyzing several proteins at the
same time32.
Structure
Prediction
The six templates were submitted to the EasyModeller and were aligned. The Discreet Optimized
Protein Energy (DOPE) score is a statistical tool to assess homology models in
protein structure prediction. The model with the minimum score can be chosen as
the best possible structure.
Validation
of Predicted Model
The validation of all the five models was
performed by using Procheck in SAVS, i.e., Structural Analysis and
Verification Server33. The Ramachandran
plot validated the result. The residues in the most favoured
region are at maximum and those in the generously allowed and disallowed
regions are at minimum.
Loop
Modeling
The loop region in the given protein very
often contribute to binding sites and determine the functional specificity of a
given protein framework. The co-ordinate file in PDB format was submitted for
loop optimization to ModLoop, i.e., Modeling of Loops in Protein Structures. ModLoop
is a web server for automated modeling of loops in protein structures. It has
been developed by Andras Fiser34,35. The resulting co-ordinate file was sent back by
e-mail. This structure was validated by using SAVS. The process of loop
modeling and subsequent validation was continued till an optimized structured
model of protein was obtained.
Ligand Generation
The literature survey revealed the
inhibitory action of Aplidin against MCM protein15.
The Aplidin (DB04977) was used to search for the
similar drugs in the Drug Bank and ZINC databases36,37.
Molecular
Docking
The molecular docking is an important tool
in structural molecular biology and computer-assisted drug designing38.
The docking of these drugs was performed by using free online server DockThor Portal. The implemented DockThor
program is a flexible-ligand and rigid-receptor grid
based method that employs a multiple solution genetic algorithm and the MMFF94S
molecular force field scoring function39. Both the macromolecule and
ligands were prepared for docking with the help of PyMol
and chemBio3D computer software respectively40,41.
The molecular docking of these drugs was done against MCM5 protein model using
online docking server DockThor. The default settings
of grid dimensions were employed. The default value of spatial discretization of the energy grid (0.25Å) was used
and the grid points were fixed at 704969.
Grid Centre: Grid Dimensions (±ΔX; ±ΔY; ±ΔZ):
Xc = 16 X
= 11
Yc = 6 Y
= 11
Zc = 20 Z
= 11
The best compound was selected on the basis
of the total energy (intermolecular ligand-receptor +
intramolecular ligand
energies) or Interaction energy (only intermolecular ligand-receptor
energy) and the root mean square deviation.
Results
And Discussion
Template
Generation
FASTA sequence of MCM5 was retrieved from
the website of NCBI. The NCBI reference sequence is CAG30403.1. The BLAST was
performed on the NCBI and 18 hits were recorded (Figure 1). The FASTA sequence
was subjected to 3D-PSSM and Phyre for prediction of
protein structure. The results obtained were combined and ranked in the descending
order of % ID. The subjection of this data to RCSB protein data bank led to the
selection of six templates (PDB ID: 3F8T, 2ENX, 1VMH, 1OFH, 2C90, 3K1J) with
their resolution < or = 3.00 Å and the R- value is < or = 0.5 (Table 1).
Table 1. Generation of templates using 3D-PSSM, Phyre and RCSB protein data bank.
S. No. |
Name |
ID % |
Resolu-tion |
R-Value |
PDBID |
1 |
3F9VA |
37 |
4.35 |
0.415 |
3F9V |
2 |
4FDGB |
37 |
4.10 |
0.332 |
4FDG |
3 |
3ZEND |
30 |
7.5 |
- |
3ZEN |
4 |
3F8TA |
29 |
1.9 |
0.214 |
3F8T |
5 |
2ENXA |
29 |
2.8 |
0.196 |
2ENX |
6 |
1VMHA |
29 |
1.31 |
0.159 |
1VMH |
7 |
1OFHA |
28 |
2.5 |
0.224 |
1OFH |
8 |
c2c90A |
28 |
2.2 |
0.209 |
2C9O |
9 |
C3K1jA |
27 |
2.0 |
0.206 |
3K1J |
10 |
2X47A |
26 |
1.7 |
0.167 |
2X47 |
11 |
3PVCA |
26 |
2.31 |
0.173 |
3PVC |
Homology
Modeling
The five models were generated with the
help of EasyModeller and their DOPE score was
obtained (Table 2). The model number 1 scored the minimum and was selected.
Validation:
The models were further validated by Procheck in SAVS. The Ramachandran
plot validated and supported the earlier decision of selecting the model number
1, as the sum of residues in most favoured region
(71.8%) and residues in additional allowed regions (21.7%) comes out to be
highest, and the sum of residues in generously allowed region (4.1%) and
residues in disallowed regions (2.3%) comes out to be lowest among all the
models (Table 2).
Loop
modeling
The PDB file format of model number 1 was
submitted for loop optimization to ModLoop and the
structure was validated by using SAVS. The model was validated as it had
maximum percentage of residues in most favoured region
(93.7%) and no residue in generously allowed as well as disallowed regions
(Figure 2).
The model of MCM5 protein (Figure 3) was successfully submitted to Protein model
data base bearing the PMDB ID: PM007964942.
Figure 1.
Distribution of 18 BLAST hits on the query sequence (query Id: Gi|47678565|emb|CAG30403.1) in pdb protein database.
Table 2. DOPE score and Ramachandran plot
statistics of the five possible models of AMF.
S. No. |
Query File Name |
Molpdf |
DOPE score |
GA341 score |
Residues in most favoured region (%) |
Residues in additional
allowed region (%) |
Residues in generously
allowed regions (%) |
Residues in disallowed
regions (%) |
1 |
B99990001.pdb |
38392.33203 |
-47071.94922 |
0.01582 |
71.8 |
21.7 |
4.1 |
2.3 |
2 |
B99990002.pdb |
39515.19141 |
-44707.50781 |
0.01502 |
71.2 |
18.7 |
5.4 |
4.7 |
3 |
B99990003.pdb |
39084.29297 |
-46161.54688 |
0.00532 |
71.7 |
20.5 |
5.2 |
2.6 |
4 |
B99990004.pdb |
38443.04297 |
-43528.59375 |
0.00862 |
73.4 |
19.4 |
4.3 |
2.9 |
5 |
B99990005.pdb |
39131.90625 |
-44203.32813 |
0.00788 |
71.8 |
20.8 |
4.4 |
2.9 |
Table 3. Docking result of ligands against MCM5 as
target.
S. No. |
Accession No. |
Total Energy (T.E) (Kcal/ mol) |
Interaction Energy (I.E) (Kcal/mol) |
Root Mean Square Deviation (RMSD) (Å) |
S. No. |
Accession No. |
Total Energy (T.E) (Kcal/mol) |
Interaction Energy (I.E) (Kcal/ mol) |
Root Mean Square Deviation (RMSD) (Å) |
1 |
ZINC15861168 |
12.855 |
-0.001 |
0.000 |
36 |
ZINC35340021 |
41.846 |
-0.001 |
0.000 |
2 |
ZINC15861121 |
17.733 |
-0.001 |
0.000 |
37 |
ZINC37538182 |
42.792 |
-0.001 |
0.000 |
3 |
ZINC15861137 |
18.545 |
-0.002 |
0.000 |
38 |
ZINC35340007 |
44.128 |
-0.002 |
0.000 |
4 |
ZINC15861138 |
21.200 |
-0.001 |
0.000 |
39 |
ZINC35340016 |
44.179 |
-0.002 |
0.000 |
5 |
ZINC35339905 |
21.562 |
-0.001 |
0.000 |
40 |
ZINC35339971 |
53.633 |
-0.001 |
0.000 |
6 |
ZINC15861184 |
21.66 |
-0.001 |
0.000 |
41 |
DB04191 |
71.356 |
-0.002 |
0.000 |
7 |
ZINC15861122 |
22.966 |
-0.001 |
0.000 |
42 |
ZINC79221126 |
75.183 |
-0.001 |
0.000 |
8 |
ZINC35339900 |
23.208 |
-0.001 |
0.000 |
43 |
ZINC79221118 |
75.386 |
-0.000 |
0.000 |
9 |
ZINC35339889 |
23.392 |
-0.001 |
0.000 |
44 |
ZINC79221195 |
76.731 |
-0.002 |
0.000 |
10 |
ZINC35339896 |
23.933 |
-0.001 |
0.000 |
45 |
ZINC79221186 |
76.940 |
-0.001 |
0.000 |
11 |
ZINC15861185 |
25.716 |
-0.001 |
0.000 |
46 |
ZINC67910488 |
77.062 |
-0.001 |
0.000 |
12 |
ZINC04665026 |
25.725 |
-0.001 |
0.000 |
47 |
ZINC79216746 |
77.231 |
-0.001 |
0.000 |
13 |
ZINC35339965 |
25.828 |
-0.001 |
0.000 |
48 |
ZINC79216743 |
77.639 |
-0.002 |
0.000 |
14 |
ZINC43766843 |
27.165 |
-0.001 |
0.000 |
49 |
ZINC79221183 |
78.273 |
-0.001 |
0.000 |
15 |
ZINC35339927 |
28.201 |
-0.001 |
0.000 |
50 |
ZINC79221177 |
78.602 |
-0.001 |
0.000 |
16 |
ZINC35339886 |
28.282 |
-0.002 |
0.000 |
51 |
ZINC67910490 |
82.136 |
-0.002 |
0.000 |
17 |
ZINC35339892 |
28.464 |
-0.002 |
0.000 |
52 |
ZINC67910485 |
82.671 |
-0.001 |
0.000 |
18 |
ZINC35339923 |
29.917 |
-0.001 |
0.000 |
53 |
ZINC67910538 |
86.164 |
-0.001 |
0.000 |
19 |
ZINC35339834 |
32.181 |
-0.001 |
0.000 |
54 |
ZINC67910540 |
86.849 |
-0.001 |
0.000 |
20 |
ZINC35339829 |
34.474 |
-0.001 |
0.000 |
55 |
ZINC67910544 |
88.506 |
-0.002 |
0.000 |
21 |
ZINC35339878 |
34.731 |
-0.001 |
0.000 |
56 |
ZINC67911060 |
89.913 |
-0.003 |
0.000 |
22 |
ZINC35339883 |
35.397 |
-0.001 |
0.000 |
57 |
DB05426 |
90.162 |
-0.001 |
0.000 |
23 |
ZINC35340003 |
35.616 |
-0.001 |
0.000 |
58 |
ZINC67911062 |
90.189 |
-0.003 |
0.000 |
24 |
ZINC67297448 |
35.936 |
-0.001 |
0.000 |
59 |
ZINC67910545 |
91.973 |
-0.001 |
0.000 |
25 |
ZINC35339969 |
37.072 |
-0.001 |
0.000 |
60 |
ZINC67911064 |
93.237 |
-0.002 |
0.000 |
26 |
DB07219 |
37.121 |
-0.001 |
0.000 |
61 |
ZINC67911067 |
94.252 |
-0.002 |
0.000 |
27 |
ZINC37538176 |
37.414 |
-0.001 |
0.000 |
62 |
DB08889 |
126.009 |
-0.000 |
0.000 |
28 |
ZINC35339909 |
37.814 |
-0.001 |
0.000 |
63 |
DB03393 |
131.549 |
-0.003 |
0.000 |
29 |
ZINC35339999 |
38.138 |
-0.001 |
0.000 |
64 |
DB04977 |
134.034 |
-0.002 |
0.000 |
30 |
ZINC35339912 |
38.277 |
-0.001 |
0.000 |
65 |
DB06663 |
138.647 |
-0.001 |
0.000 |
31 |
ZINC67297434 |
38.509 |
-0.002 |
0.000 |
66 |
DB08890 |
150.493 |
-0.004 |
0.000 |
32 |
ZINC37538178 |
38.994 |
-0.001 |
0.000 |
67 |
DB01723 |
157.154 |
-0.168 |
0.000 |
33 |
ZINC35339967 |
39.674 |
-0.001 |
0.000 |
68 |
DB05128 |
159.637 |
-0.003 |
0.000 |
34 |
ZINC37538180 |
40.857 |
-0.001 |
0.000 |
69 |
DB01369 |
187.235 |
-0.002 |
0.000 |
35 |
ZINC01380951 |
41.81 |
-0.001 |
0.000 |
|
|
|
|
|
Ligand Generation
From the Drugbank
and ZINC databases sixty nine (69) compounds similar to Aplidin
were selected.
Molecular
Docking
The molecular docking of these 69 compounds
was done against the model of MCM5 protein using the online server DockThor (Table 3). The results suggested that the docking
of the compound ZINC15861168 (acetonyl-cycloheptyl-cyclohexyl-BLAHtrione)
with MCM5 protein was held with least total energy of 12.855 Kcal/mol and
interaction energy of -0.001 Kcal/mol when compared with the compound Aplidin (total energy: 134.034 Kcal/mol; interaction
energy: -0.002 Kcal/mol).
Figure 2. Ramachandran plot for optimized model
of MCM5 protein.
Figure 3. Optimized model of MCM 5
protein.
Conclusion:
The model of MCM5 protein was created by
using the concepts of homology and loop modeling. The model was validated by
the Ramachandran plot. Various ligands were
identified using Drug bank and ZINC database. The molecular docking done
against MCM5, of these ligands using online docking server Dockthor
identified compound ZINC15861168 (acetonyl-cycloheptyl-cyclohexyl-BLAHtrione)
with least total energy of 12.855 Kcal/mol. The study suggested that the above
said compound bears the minimum binding energy with MCM5 protein and thus has
the maximum probability to bind with it. Thus, the usage of this compound can
lead to inhibition of the protein MCM5 which will act as a barricade in the
formation of heteromeric complex of MCM2-7 proteins
thereby assisting in the treatment of multiple myeloma and other cancer cells.
References:
1 Dudderidge TJ et
al. Diagnosis of
prostate cancer by detection of minichromosome
maintenance 5 protein in urine sediments. British
Journal of Cancer. 103 (5);
2010: 701-707.
2 Synder M, Huang
XY and Zhang
JJ. The minichromosome maintenance proteins 2-7
(MCM2-7) are necessary for RNA polymerase II (Pol
II)-mediated transcription. Journal of Biological Chemistry.
284 (20); 2009: 13466-13472.
3 Gauthier L et al. The
role of the carboxyterminal domain of RNA polymerase
II in regulating origins of DNA replication in Saccharomyces cerevisiae. Genetics. 162 (3); 2002: 1117-1129.
4 Hill AL, Phelan SA and Loeken
MR. Reduced expression of pax-3 is associated with over expression of cdc46 in
the mouse embryo. Development Genes and Evolution. 208
(3); 1998: 128-134.
5 Miyake S and Yamashita S. Identification
of sna41 gene, which is the suppressor of nda4 mutation and is involved in DNA
replication in Schizosaccharomyces pombe. Genes to Cells: devoted to cellular and molecular
mechanisms. 3 (3); 1998: 157-166.
6 Synder M, He W
and Zhang JJ. The DNA replication factor MCM5 is essential for Stat1-mediated
transcriptional activation. Proceedings of the National
Academy of Sciences of the United States of America. 102 (41); 2005:
14539-14544.
7 Wikipedia. MCM5. Wikipedia [cited 2014 Nov 8]. Available from:
http://www.en.wikipedia.org/wiki/MCM5
8 Stoeber
K et al. Diagnosis of genito-urinary tract cancer by
detection of Minichromosome Maintenance 5 protein in
urine sediments. Journal of the National Cancer Institute. 94 (14); 2002:
1071-1079.
9 Yu SY et al. Increased
expression of MCM5 is significantly associated with aggressive progression and
poor prognosis of oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 43 (5); 2014:
344-349.
10 Liu H et al. Expression
of minichromosome maintenance 5 protein in
proliferative and malignant skin diseases. International Journal of Dermatology. 46 (11); 2007: 1171-1176.
11 Going JJ et al. Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in
dysplastic squamous oesophageal
epithelium and Barrett’s mucosa. Gut. 50 (3); 2002: 373-377.
12 Giaginis C et al.
MCM-2 and MCM-5 expression in gastric adenocarcinoma:
clinical significance and comparison with Ki-67 proliferative marker. Digestive Diseases and Sciences. 56 (3); 2011: 777-785.
13 Saydam O et al.
Comparative protein profiling reveals minichromosome
maintenance (MCM) proteins as novel potential tumor markers for meningiomas. Journal of Proteome
Research. 9 (1); 2010:
485-494.
14 Ayaru L et al.
Diagnosis of pancreaticobiliary malignancy by
detection of minichromosome maintenance protein 5 in
bile aspirates. British Journal of Cancer. 98 (9); 2008: 1548-1554.
15 Mitsiades CS et
al. Aplidin, a marine organism-derived compound with
potent antimyeloma activity in vitro and in vivo. Cancer Research. 68 (13); 2008: 5216-5225.
16 Rizwani W, Alexandrow M and Chellappan S. Prohibitin physically interacts
with MCM proteins and inhibits mammalian DNA replication. Cell
Cycle. 8 (10); 2009:
1621-1629.
17 Krieger E, Nabuurs
SB and Vriend G. Homology Modeling. In Structural Bioinformatics, Edited by Bourne PE and Weissig H. John Wiley & Sons, Inc, Hoboken, NJ, USA.
2005; Vol 44: pp. 507-521.
18 Webb B and Sali A.
Comparative protein structure modeling using MODELLER. Current
Protocols in Bioinformatics. 47;
2014: 5.6.1-5.6.32.
19 Du H et al. Protein structure prediction provides comparable performance to
crystallographic structures in docking-based virtual screening. Methods. 71 (1); 2015: 77-84.
20 Sivakamavalli J et
al. Homology modelling, molecular dynamics, and
docking studies of pattern-recognition transmembrane
protein-lipopolysacccharide and β-1,3 glucan-binding protein from Fenneropenaeus indicus. Journal of Biomolecular structure and
Dynamics. 20; 2014: 1-12.
21 Khan N et al. Insilico approach to predict the structure of amyloid precursor protein responsible for Alzheimer disease. Journal of Advanced
Bioinformatics Applications and Research. 3 (2); 2012: 333-338.
22 Wikipedia. FASTA. Wikipedia [cited 2014 May 06]. Available
from: http://www.en.wikipedia.org/wiki/FASTA
23 National Centre for Biotechnology
Information. MCM5 homo
sapiens [FASTA]. National Centre for
Biotechnology Information [cited 2014 May 06]. Available from:
http://www.ncbi.nlm.nih.gov/protein/47678565?report=fasta
24 Wikipedia. BLAST. Wikipedia [cited 2014 May 06]. Available from:
http://www.en.wikipedia.org/wiki/BLAST
25 Kelley L. 3D-PSSM
(Version 2.6.0). 3D-PSSM protein fold recognition (threading)
server [cited 2014 May 06]. Available from: http://www.sbg.bio.ic.ac.uk/~3dpssm/index2.html
26 Wikipedia. Phyre/Phyre2. Wikipedia [cited 2014 May 06]. Available
from: http://www.en.wikipedia.org/wiki/Phyre_/_Phyre2
27 Kelley L et al. Phyre2 (Version
2). Protein homology analogy recognition
server [cited 2014 May 06]. Available from: http://www.sbg.bio.ic.ac.uk/phyre2
28 Berman HM et al. The
Protein data bank. Nucleic Acids Research. 28 (1); 2000: 235-242.
29 Research Collaboratory
for Structural Bioinformatics-Protein Data Bank. RCSB Protein Data Bank- RCSB
PDB (An information portal to biological macromolecular structures) [cited 2014
May 08]. Available from: http://www.rcsb.org
30 Bhusan KK. EasyModeller (Version 2.0) {Computer software} [cited 2014
May 08]. Available from: http://www.sites.google.com/site/bioinformatikz
31 Bhusan KK, Aparoy P and Reddanna P. EasyModeller: A graphical interface to MODELLER. BMC Research Notes. 3; 2010: 226.
32 Guex N et al. DeepView-Swiss-PdbViewer (Version
4.1) {Computer software} [cited 2014 May 06]. Available from: http://www.Spdbv.vital-it.ch/
33 NIH MBI Laboratory
for Structural Genomics and Proteomics. Structural Analysis
and Verification Server (Version 3). UCLA MBI-SAVES web server [cited
2014 May 10]. Available from: http://www.nihserver.mbi.ucla.edu/SAVES/
34 Fiser A and Sali A. ModLoop: automated
modeling of loops in protein structures. Bioinformatics. 19 (18); 2003:
2500-2501.
35 Fiser A. ModLoop (Version r204). ModLoop-ModBase
web server [cited 2014 May 11]. Available from: https://modbase.compbio.ucsf.edu/modloop/
36 Shoichet
Laboratory. ZINC {Data set} [cited
2014 May 23]. Available from: http://www.zinc.docking.org
37 The Metabolomics
Innovation Centre. Drug Bank {Data
set} [cited 2014 May 21]. Available from: http://www.drugbank.ca
38 Morris GM and Lim-Wilby
M. Molecular docking. Methods in Molecular Biology.
443; 2008: 365-382.
39 GMMSB/LNCC. The DockThor
Portal (Version 1.0) {Online docking server} [cited
2014 November]. Available from: http://www.dockthor.Incc.br
40 PerkinElmer. ChemBio3D (Ultra 13.0)
{Computer software} [cited 2014 November 12]. Available from:
http://www.cambridgesoft.com/Ensemble_for_chemistry/chemBio3D/
41 Schrödinger. PyMol
(Version 1.7.2) {Computer software} [cited 2014 November 12]. Available from:
http://www.pymol.org
42 CASPUR & University
of Rome “La Sapienza. (2014). Protein Model Data Base {Data Base} [cited 2014 August 28].
Available from: http://bioinformatics.cineca.it/PMDB/
Received on 20.02.2015 Accepted on 10.03.2015
© Asian Pharma
Press All Right Reserved
Asian J. Pharm.
Tech. 2015; Vol. 5: Issue 1, Pg
17-22
DOI: 10.5958/2231-5713.2015.00004.5